Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedJul 01, 2022
DataAggregated Company Financials
Companies6
  • 7D1.9%
  • 3M-54.3%
  • 1Y-73.0%
  • YTD-51.4%

In the last week, the Biotech industry is up 3.0%, with Basilea Pharmaceutica up 7.5%. In the same time, Idorsia was down 5.1%. In the past year, the industry is down 74%. As for the next few years, earnings are forecast to decline by 70% per annum.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 01 Jul 2022CHF545.5mCHF454.2mCHF80.7m2.2x
Sun, 29 May 2022CHF663.3mCHF466.3mCHF24.4m2.1x
Tue, 26 Apr 2022CHF983.0mCHF295.7m-CHF141,995,551.002x
Thu, 24 Mar 2022CHF1.2bCHF285.2m-CHF139,056,618.002x
Sat, 19 Feb 2022CHF1.3bCHF281.7m-CHF139,042,754.001.8x
Mon, 17 Jan 2022CHF5.1bCHF315.7m-CHF659,256,312.001.5x
Wed, 15 Dec 2021CHF3.8bCHF318.6m-CHF658,847,613.001.5x
Fri, 12 Nov 2021CHF4.1bCHF317.8m-CHF658,961,348.001.5x
Sun, 10 Oct 2021CHF4.9bCHF287.4m-CHF590,849,719.002.3x
Tue, 07 Sep 2021CHF5.2bCHF305.7m-CHF612,309,374.801.1x
Thu, 05 Aug 2021CHF5.4bCHF306.0m-CHF612,309,374.801.1x
Sun, 09 May 2021CHF5.5bCHF352.3m-CHF535,605,963.801.1x
Wed, 10 Feb 2021CHF7.0bCHF407.2m-CHF561,055,198.506.3x
Tue, 03 Nov 2020CHF6.2bCHF399.6m-CHF565,530,866.507.4x
Fri, 07 Aug 2020CHF4.3bCHF393.6m-CHF565,357,804.5028.6x
Thu, 30 Apr 2020CHF835.1mCHF327.2m-CHF114,875,385.506.6x
Sun, 02 Feb 2020CHF5.0bCHF460.8m-CHF670,400,644.00n/a
Wed, 06 Nov 2019CHF3.6bCHF473.1m-CHF646,955,470.00n/a
Sat, 10 Aug 2019CHF3.4bCHF449.1m-CHF654,647,900.00n/a
Median PE Ratio

n/a


Total Market Cap: CHF3.6bTotal Earnings: -CHF654,647,900.00Total Revenue: CHF449.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Median PE3Y Average 17.8x202020212022
Current Industry PE
  • Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 6.7x which is higher than its 3-year average PE of -7.1x.
  • The industry's 3-year average PS ratio 11.2x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have gone up over the last three years, and the industry is now profitable.
  • Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.

Industry Comparison

How does Swiss Biotech compare with similar industries?

CH Market2.45%
Healthcare3.61%
Biotech1.95%
Biotech1.95%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BSLN Basilea PharmaceuticaCHF38.607.5%
+CHF32.0m
-13.3%PS3.1x
RLF Relief Therapeutics HoldingCHF0.03315.8%
+CHF18.5m
-83.0%PS41.1x
WBIO Wockhardt BioCHF1.5817.0%
+CHF11.9m
n/aPE2.3x
KURN Kuros BiosciencesCHF1.852.5%
+CHF1.5m
-21.6%PS4.4x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IDIA

CHF13.65

Idorsia

7D

-5.1%

1Y

-46.5%

SPEX

CHF0.96

Spexis

7D

-12.1%

1Y

n/a